Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 28th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 89% | 90% | 84% | 4.50 | 4.20 | 4.00 | 4.30 | 3.80 | 3.90 | 24.00 | 16.00 | 46.00 | 98.00 | 280.00 | 464.00 | 496.00 | 412.00 | 5.172% | 3.448% | 9.914% | 21.121% | 60.345% | 45.00 | 1212 | 0.56 | 0.19 | 0.26 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 28th, 2024 04:27PM | Apr 28th, 2024 04:27PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 26th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 89% | 90% | 84% | 4.50 | 4.20 | 4.00 | 4.30 | 3.80 | 3.90 | 24.00 | 16.00 | 46.00 | 98.00 | 281.00 | 465.00 | 496.00 | 412.00 | 5.161% | 3.441% | 9.892% | 21.075% | 60.43% | 45.00 | 1211 | 0.56 | 0.19 | 0.26 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 26th, 2024 08:13AM | Apr 26th, 2024 08:13AM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 25th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 89% | 90% | 84% | 4.50 | 4.20 | 4.00 | 4.30 | 3.80 | 3.90 | 24.00 | 16.00 | 46.00 | 98.00 | 281.00 | 465.00 | 496.00 | 412.00 | 5.161% | 3.441% | 9.892% | 21.075% | 60.43% | 45.00 | 1211 | 0.56 | 0.19 | 0.26 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 25th, 2024 06:35PM | Apr 25th, 2024 06:35PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 24th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 89% | 90% | 85% | 4.50 | 4.20 | 4.00 | 4.30 | 3.80 | 3.90 | 25.00 | 16.00 | 46.00 | 98.00 | 281.00 | 466.00 | 496.00 | 412.00 | 5.365% | 3.433% | 9.871% | 21.03% | 60.3% | 45.00 | 1211 | 0.56 | 0.19 | 0.26 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 24th, 2024 10:59AM | Apr 24th, 2024 10:59AM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 23rd, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 89% | 90% | 84% | 4.50 | 4.20 | 4.00 | 4.30 | 3.80 | 3.90 | 25.00 | 16.00 | 46.00 | 98.00 | 280.00 | 465.00 | 495.00 | 411.00 | 5.376% | 3.441% | 9.892% | 21.075% | 60.215% | 45.00 | 1209 | 0.56 | 0.19 | 0.26 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 23rd, 2024 04:32PM | Apr 23rd, 2024 04:32PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 21st, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 88% | 89% | 84% | 4.40 | 4.20 | 3.90 | 4.30 | 3.80 | 3.90 | 26.00 | 16.00 | 46.00 | 97.00 | 279.00 | 464.00 | 492.00 | 407.00 | 5.603% | 3.448% | 9.914% | 20.905% | 60.129% | 45.00 | 1209 | 0.56 | 0.19 | 0.25 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 21st, 2024 04:33PM | Apr 21st, 2024 04:33PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 20th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 88% | 89% | 84% | 4.40 | 4.20 | 3.90 | 4.30 | 3.80 | 3.90 | 26.00 | 16.00 | 46.00 | 97.00 | 279.00 | 464.00 | 492.00 | 407.00 | 5.603% | 3.448% | 9.914% | 20.905% | 60.129% | 45.00 | 1209 | 0.56 | 0.19 | 0.25 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 20th, 2024 04:48PM | Apr 20th, 2024 04:48PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 19th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 88% | 89% | 84% | 4.40 | 4.20 | 3.90 | 4.30 | 3.80 | 3.90 | 26.00 | 16.00 | 46.00 | 97.00 | 281.00 | 466.00 | 492.00 | 407.00 | 5.579% | 3.433% | 9.871% | 20.815% | 60.3% | 45.00 | 1208 | 0.56 | 0.19 | 0.25 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 19th, 2024 07:46AM | Apr 19th, 2024 07:46AM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 18th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 88% | 89% | 84% | 4.40 | 4.20 | 3.90 | 4.30 | 3.80 | 3.90 | 26.00 | 16.00 | 46.00 | 97.00 | 281.00 | 466.00 | 492.00 | 407.00 | 5.579% | 3.433% | 9.871% | 20.815% | 60.3% | 45.00 | 1208 | 0.56 | 0.19 | 0.25 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 18th, 2024 06:08PM | Apr 18th, 2024 06:08PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||||||
nasdaq:vrtx | https://www.glassdoor.com?employer_id=2080 | 2080 | Apr 17th, 2024 12:00AM | Open | Vertex Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Boston, MA | 1989 | 4.20 | 88% | 89% | 84% | 4.40 | 4.20 | 3.90 | 4.30 | 3.80 | 3.90 | 26.00 | 16.00 | 46.00 | 97.00 | 280.00 | 465.00 | 492.00 | 407.00 | 5.591% | 3.441% | 9.892% | 20.86% | 60.215% | 45.00 | 1208 | 0.56 | 0.19 | 0.25 | 0.66 | 0.10 | 0.11 | 0.01 | 0.03 | 0.03 | Open | Reshma Kewalramani | Apr 17th, 2024 02:35PM | Apr 17th, 2024 02:35PM | Vertex Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |